Piper Sandler Maintains Neutral on Exact Sciences, Raises Price Target to $70

Piper Sandler analyst David Westenberg maintains Exact Sciences (NASDAQ:EXAS) with a Neutral and raises the price target from $50 to $70.

Piper Sandler analyst David Westenberg maintains Exact Sciences (NASDAQ:EXAS) with a Neutral and raises the price target from $50 to $70.

Total
0
Shares
Related Posts